Ahmed Naguy

Stimulants are a first-line treatment modality in the ADHD pharmacotherapy guidelines; yet, many subjects in clinical trials show an inadequate response. Read the case of a 14-year-old boy with...

Here, the author provides an anthology of psychiatric eponyms. Clinically, many of these described syndromes represent valid diagnostic constructs and may accommodate the atypical cases that defy the official...

In this letter to the editor, the author attempts to speculate on the link between autism spectrum disorder and gender dysphoria. Read on to find out more.

Paroxetine is an selective serotonin reuptake inhibitor approved by the FDA for adult depression, obsessive-compulsive disorder, anxiety disorders, and vasomotor changes of menopause. Nonetheless, its clinical use has recently...

While paroxetine may have lost favor with some, it still has therapeutic potential in the treatment of various disorders. In this letter to the editor, the author urges clinicians...

Read a case of the antidepressant, Vortioxetine, which induced mania, causing graphorrhea in a bipolar patient.

In this letter to the editor, Dr Naguy comments on a case report previously published in the PCC.

Levetiracetam is often prescribed by neurologists. This report sheds light on the psychiatric sequelae associated with levetiracetam while highlighting clinical correlates and management issues.

In this brief report, Dr Naguy discusses lithium's antisuicidal effects in patients with bipolar mood disorder.

In this letter to the editor, Dr Naguy comments on a report previously published in the PCC.

In this brief report, Dr Naguy provides an overview of transdermal psychotropic medications.

This report describes the case of a 4-year-old boy with behaviors consistent with pica. Read on to find out more about this interesting case.

Here, read about the case of a child with metabolic-prone essential autism spectrum disorder and mild intellectual disability with a severe behavioral component that responded to low-dose sulpiride.

The issues related to the COVID-19 pandemic pose a unique challenge for those with autism spectrum disorder and their caregivers as well. Read this commentary to find out more.

In this report, the author discusses the assessment, diagnosis, and treatment of depression in patients with autism spectrum disorder. Read on to find out more.

The negative symptom domain in schizophrenia is pervasive, sometimes invisible, and difficult to treat. Here, read about a patient with chronic schizophrenia who experienced improvement in the negative symptom...

Here, read about sluggish cognitive tempo, a set of behavioral symptoms characterized by daydreaming, mental fogginess, and slowed behavior/mentation, and how it differs from ADHD.